Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
19.1M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2.08M
-
Shares change
-
+1.99M
-
Total reported value, excl. options
-
$13.7M
-
Value change
-
+$13.1M
-
Put/Call ratio
-
0.03
-
Number of buys
-
22
-
Number of sells
-
-1
-
Price
-
$6.59
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q4 2021
27 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q4 2021.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.08M shares
of 19.1M outstanding shares and own 10.87% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (782K shares), VANGUARD GROUP INC (279K shares), ACT CAPITAL MANAGEMENT, LLC (263K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219K shares), TWO SIGMA ADVISERS, LP (80.9K shares), GEODE CAPITAL MANAGEMENT, LLC (80K shares), Velan Capital Investment Management LP (74.5K shares), TWO SIGMA INVESTMENTS, LP (67.3K shares), MORGAN STANLEY (56.7K shares), and Kepos Capital LP (50K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.